Same Indication

Nivolumab vs Telmisartan

Nivolumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between Nivolumab and Telmisartan.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Telmisartan — 24 hours.

Chemical Properties

Molecular Formula: Telmisartan — C33H30N4O2.

Molecular Weight: Telmisartan — 514.6230 g/mol.

Type: Nivolumab — Antibody; Telmisartan — Small molecule.